Literature DB >> 30265132

Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

Melina J Windon1, Gypsyamber D'Souza1,2, Carole Fakhry1,2,3.   

Abstract

The population of survivors with human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC) is rising. The improved prognosis of this etiologic subset is reflected in new staging guidelines as well as ongoing deintensification trials aiming to preserve excellent survival while decreasing treatment-related toxicities. However, as staging criteria and treatment standards evolve in the era of transoral surgery and deintensification, little is known regarding the needs and treatment preferences of patients with HPV-OPSCC. Herein, the current knowledge regarding treatment preferences and priorities, quality of life and concerns among patients with HPV-OPSCC is reviewed.

Entities:  

Keywords:  human papillomavirus; oropharyngeal cancer; otolaryngology; patient preference; radiotherapy; robotic surgical procedures; shared decision-making;  head and neck cancer

Mesh:

Year:  2018        PMID: 30265132      PMCID: PMC6275561          DOI: 10.2217/fon-2018-0063

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  77 in total

1.  The influence of ill-health experience on the valuation of health.

Authors:  X Badia; M Herdman; P Kind
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

2.  Patient preferences for oropharyngeal cancer treatment de-escalation.

Authors:  Drew C Brotherston; Ian Poon; Tuyen Le; Martin Leung; Alex Kiss; Jolie Ringash; Judith Balogh; Justin Lee; James R Wright
Journal:  Head Neck       Date:  2012-03-20       Impact factor: 3.147

3.  Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Yuehan Zhang; Samantha Merritt; Dorothy Gold; Hilary A Robbins; Victoria Buckman; Jennifer Gerber; David W Eisele; Patrick Ha; Joseph Califano; Carole Fakhry
Journal:  Oral Oncol       Date:  2016-07-17       Impact factor: 5.337

4.  Priorities for the head and neck cancer patient, their companion and members of the multidisciplinary team and decision regret.

Authors:  S S Gill; J Frew; A Fry; J Adam; V Paleri; W Dobrowsky; S Chatterjee; C G Kelly
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-05-06       Impact factor: 4.126

5.  Transoral laser surgery for pharyngeal and pharyngolaryngeal carcinomas.

Authors:  Jürg Kutter; Florian Lang; Philippe Monnier; Philippe Pasche
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-02

6.  Patient Reflections on Decision Making for Laryngeal Cancer Treatment.

Authors:  Andrew G Shuman; Knoll Larkin; Dorothy Thomas; Frank L Palmer; Joseph J Fins; Shrujal S Baxi; Nancy Lee; Jatin P Shah; Angela Fagerlin; Snehal G Patel
Journal:  Otolaryngol Head Neck Surg       Date:  2017-01-24       Impact factor: 3.497

7.  Patients preferences in chemotherapy for advanced non-small-cell lung cancer.

Authors:  Takashi Hirose; Naoya Horichi; Tohru Ohmori; Sohjiroh Kusumoto; Tomohide Sugiyama; Takao Shirai; Tetsuji Ozawa; Tsukasa Ohnishi; Mitsuru Adachi
Journal:  Intern Med       Date:  2005-02       Impact factor: 1.271

8.  Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers.

Authors:  Yogesh I More; Terance T Tsue; Douglas A Girod; John Harbison; Kevin J Sykes; Carson Williams; Yelizaveta Shnayder
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-01       Impact factor: 6.223

9.  Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients.

Authors:  Marcy A List; Judith Lee Rutherford; John Stracks; Barbara Roa Pauloski; Jerilyn A Logemann; Donna Lundy; Paula Sullivan; William Goodwin; Merrill Kies; Everett E Vokes
Journal:  Head Neck       Date:  2004-02       Impact factor: 3.147

10.  Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi).

Authors:  Glyn Elwyn; Annette M O'Connor; Carol Bennett; Robert G Newcombe; Mary Politi; Marie-Anne Durand; Elizabeth Drake; Natalie Joseph-Williams; Sara Khangura; Anton Saarimaki; Stephanie Sivell; Mareike Stiel; Steven J Bernstein; Nananda Col; Angela Coulter; Karen Eden; Martin Härter; Margaret Holmes Rovner; Nora Moumjid; Dawn Stacey; Richard Thomson; Tim Whelan; Trudy van der Weijden; Adrian Edwards
Journal:  PLoS One       Date:  2009-03-04       Impact factor: 3.240

View more
  6 in total

1.  Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.

Authors:  Elaine O Bigelow; Melina J Windon; Carole Fakhry; Ana P Kiess; Tanguy Seiwert; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2021-11-22       Impact factor: 5.337

2.  Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.

Authors:  M Ravanelli; A Grammatica; M Maddalo; M Ramanzin; G M Agazzi; E Tononcelli; S Battocchio; P Bossi; M Vezzoli; R Maroldi; D Farina
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

3.  Priorities, concerns, and regret among patients with head and neck cancer.

Authors:  Melina J Windon; Gypsyamber D'Souza; Farhoud Faraji; Tanya Troy; Wayne M Koch; Christine G Gourin; Ana P Kiess; Karen T Pitman; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

4.  Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study.

Authors:  Melina J Windon; Daisy Le; Gypsyamber D'Souza; Elaine Bigelow; Karen Pitman; Emily Boss; David W Eisele; Carole Fakhry
Journal:  Oral Oncol       Date:  2020-10-30       Impact factor: 5.337

Review 5.  Special Issue about Head and Neck Cancers: HPV Positive Cancers.

Authors:  Panagiota Economopoulou; Ioannis Kotsantis; Amanda Psyrri
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

Review 6.  Imaging biomarkers in upper gastrointestinal cancers.

Authors:  Michela Gabelloni; Lorenzo Faggioni; Emanuele Neri
Journal:  BJR Open       Date:  2019-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.